These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9805025

  • 21. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
    Flan B, Arrabal S.
    Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
    [Abstract] [Full Text] [Related]

  • 22. Commentary: The risk of variant Creutzfeldt-Jakob Disease: reassurance and uncertainty.
    Will RG.
    Int J Epidemiol; 2005 Feb; 34(1):52-3. PubMed ID: 15649957
    [No Abstract] [Full Text] [Related]

  • 23. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000.
    Fogden M, Whitehorn K, Starr D, Persaud R, Hannaford R, Barbara J, Love E, Robinson A, Ferguson E, Turner G, Wallington T, Klein H, Franklin I, Fry R.
    Transfus Med; 2001 Apr; 11(2):136-45. PubMed ID: 11583001
    [No Abstract] [Full Text] [Related]

  • 27. Creutzfeldt-Jakob disease.
    Clement P.
    Haemophilia; 2000 Jul; 6 Suppl 1():68-78. PubMed ID: 10982271
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Balancing evidence and public opinion in health technology assessments: the case of leukoreduction.
    Cleemput I, Leys M, Ramaekers D, Bonneux L.
    Int J Technol Assess Health Care; 2006 Jul; 22(4):403-7. PubMed ID: 16984672
    [Abstract] [Full Text] [Related]

  • 30. Can CJD be transmitted through the blood supply.
    Larke B.
    CMAJ; 1998 Mar 24; 158(6):714-5. PubMed ID: 9538848
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
    van Aken WG.
    Ned Tijdschr Geneeskd; 2001 Jul 28; 145(30):1444-7. PubMed ID: 11503311
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Japan's beef scandal.
    Nature; 2001 Sep 27; 413(6854):333. PubMed ID: 11574833
    [No Abstract] [Full Text] [Related]

  • 35. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
    Sutton JM, Dickinson J, Walker JT, Raven ND.
    Clin Infect Dis; 2006 Sep 15; 43(6):757-64. PubMed ID: 16912952
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Careful monitoring of Creutzfeldt-Jakob disease. No cases of the new variant of CJD discovered in Sweden so far].
    Nygård K, Arneborn M, Giesecke J.
    Lakartidningen; 2001 Oct 24; 98(43):4697-9. PubMed ID: 11715245
    [No Abstract] [Full Text] [Related]

  • 38. Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels.
    Rábano A, de Pedro-Cuesta J, Mølbak K, Siden A, Calero M, Laursen H, EUROSURGYCJD Research Group.
    BMC Public Health; 2005 Jan 24; 5():9. PubMed ID: 15667663
    [Abstract] [Full Text] [Related]

  • 39. The impact of new-variant Creutzfeldt-Jakob disease on blood transfusion practice.
    Turner M.
    Br J Haematol; 1999 Sep 24; 106(4):842-50. PubMed ID: 10519983
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.